Cedar Brook Financial Partners, LLC Danaher Corp Transaction History

Cedar Brook Financial Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$224.58 - $256.19 $42,221 - $48,163	-188 Reduced 7.75%	2,239 $559,000
Q4 2023 Jan 12, 2024	BUY	$185.1 - $233.13 $133,827 - $168,552	723 Added 42.43%	2,427 $561,000
Q3 2023 Oct 17, 2023	SELL	$233.08 - $265.59 $76,916 - $87,644	-330 Reduced 16.22%	1,704 $422,000
Q2 2023 Jul 05, 2023	BUY	$224.99 - $256.14 $15,299 - $17,417	68 Added 3.46%	2,034 $488,000
Q1 2023 Apr 04, 2023	BUY	$239.75 - $277.0 $63,294 - $73,128	264 Added 15.51%	1,966 $495,000
Q4 2022 Feb 01, 2023	SELL	$241.42 - $282.29 $2,172 - $2,540	-9 Reduced 0.53%	1,702 $451,000
Q3 2022 Jan 03, 2023	BUY	$247.06 - $1507.4 $16,058 - $97,981	65 Added 3.95%	1,711 $441,000
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $24,659 - $31,164	104 Added 6.74%	1,646 $417,000
Q1 2022 Apr 06, 2022	SELL	$257.27 - $315.76 $94,932 - $116,515	-369 Reduced 19.31%	1,542 $452,000
Q4 2021 Jan 27, 2022	SELL	$292.08 - $329.01 $15,188 - $17,108	-52 Reduced 2.65%	1,911 $629,000
Q3 2021 Nov 01, 2021	SELL	$272.21 - $332.43 $32,937 - $40,224	-121 Reduced 5.81%	1,963 $598,000
Q2 2021 Aug 16, 2021	BUY	$225.08 - $271.69 $74,726 - $90,201	332 Added 18.95%	2,084 $559,000
Q1 2021 May 11, 2021	BUY	$212.38 - $245.9 $52,670 - $60,983	248 Added 16.49%	1,752 $394,000
Q4 2020 Feb 12, 2021	BUY	$212.5 - $245.46 $106,462 - $122,975	501 Added 49.95%	1,504 $334,000
Q3 2020 Nov 09, 2020	BUY	$177.16 - $215.33 $177,691 - $215,975	1,003 New	1,003 $215,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.